In the US, Coumadin (warfarin systemic) is a member of the drug class coumarins and indandiones and is used to treat Antiphospholipid Syndrome, Chronic Central Venous Catheterization, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - First Event, Deep Vein Thrombosis - Recurrent Event, Heart Attack, Heart Failure, Prevention of Thromboembolism in Atrial Fibrillation, Prosthetic Heart Valves - Thrombosis Prophylaxis, Prosthetic Heart Valves - Mechanical Valves - Thrombosis Prophylaxis, Prosthetic Heart Valves - Tissue Valves - Thrombosis Prophylaxis, Protein S Deficiency, Pulmonary Embolism - First Event, Pulmonary Embolism - Recurrent Event and Thromboembolic Stroke Prophylaxis.
Ingredient matches for Coumadin
Warfarin is reported as an ingredient of Coumadin in the following countries:
Warfarin sodium (a derivative of Warfarin) is reported as an ingredient of Coumadin in the following countries:
- New Zealand
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.